Q3 2024 EPS Estimates for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Reduced by Analyst

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Analysts at Zacks Research decreased their Q3 2024 earnings per share (EPS) estimates for Acadia Healthcare in a research report issued on Monday, October 14th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings of $0.88 per share for the quarter, down from their previous estimate of $0.90. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.51 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.83 EPS, FY2024 earnings at $3.46 EPS, Q1 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.98 EPS, Q4 2025 earnings at $1.05 EPS, FY2025 earnings at $3.86 EPS and Q1 2026 earnings at $0.93 EPS.

ACHC has been the topic of several other research reports. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lifted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Barclays lowered their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Friday, September 20th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Stock Up 0.1 %

ACHC stock opened at $56.96 on Wednesday. Acadia Healthcare has a fifty-two week low of $53.22 and a fifty-two week high of $87.77. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of -406.86, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The business’s 50 day moving average price is $71.64 and its two-hundred day moving average price is $69.88.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The firm had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business’s revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned $0.92 earnings per share.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Blue Trust Inc. lifted its position in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares in the last quarter. Mather Group LLC. purchased a new position in shares of Acadia Healthcare in the first quarter valued at approximately $48,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Acadia Healthcare during the 2nd quarter valued at about $59,000. Finally, nVerses Capital LLC acquired a new position in shares of Acadia Healthcare during the 2nd quarter valued at about $95,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.